Drug discovery has to change — and we reimagine the path from target to hit, lead, and candidate by leveraging the power of Ulysses®, our unique, integrated drug discovery platform.
Data is the lifeblood of research, and better data leads to better decisions.
We combine robotics, data science, and machine learning to make better decisions based on robust, reliable, and reproducible data both for our wholly-owned and our partnered programs. Our platform enables us to make the right decisions at the right time, and move novel programs towards the clinic faster.
We validate novel targets using the latest cell and molecular biology techniques
Learn moreWe identify hits using both computational design and in vitro screening approaches
Learn moreWe develop hits into leads with our sector-defining biochemical abilities
Learn moreWe optimize leads with signisicantly reduced cycle times
Learn moreWe take your programs all the way to IND-enabling studies
Learn moreOur fully automated wet lab that generates superior quality data at scale, feeding into our data lake and powering our decision-making from target to hit, lead, and candidate.
Our integrated data architecture that captures and analyzes experimental data in real-time, closing the loop with advanced machine learning algorithms.
We work with select biotech companies, pharmaceutical corporations, and AI drug discovery companies from across the world to bring new drugs to patients faster.
To keep up with the latest news and important developments in AI drug discovery, subscribe here to receive the quarterly Arctoris Report prepared by our experts